PINK:OTLC

Oncotelic Therapeutics Stock Insider Trading

etoro logo Buy OTLC
*Your capital is at risk
$0.0500
+0 (+0%)
At Close: Jun 03, 2026

Oncotelic Therapeutics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 251.52M and sold 52.51K OTLC shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
100.00
Buy 251.52M shares
Sell 52.51K shares
92% Buy Activity
Weak Positive Correlation

No Significant Signals

No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date Type Person Role Amount
Jun 14, 2023
Buy
Common Stock
P-Purchase
Trieu Vuong
Chairman And CEO
CEO / President 400 000
Value: $13.0K
May 26, 2023
Buy
Common Stock
P-Purchase
Trieu Vuong
Chairman And CEO
CEO / President 126 888
Value: $4K
May 26, 2023
Buy
Common Stock
P-Purchase
Trieu Vuong
Chairman And CEO
CEO / President 126 888
Value: $4K
May 02, 2023
Buy
Common Stock
P-Purchase
Trieu Vuong
Chairman And CEO
CEO / President 100 000
Value: $5K
May 02, 2023
Buy
Common Stock
P-Purchase
Trieu Vuong
Chairman And CEO
CEO / President 100 000
Value: $5K
Dec 06, 2022
Buy
Common Stock
P-Purchase
Trieu Vuong
Chairman And CEO
CEO / President 120 000
Value: $6K
Dec 06, 2022
Buy
Common Stock
P-Purchase
Trieu Vuong
Chairman And CEO
CEO / President 120 000
Value: $6K
Nov 22, 2022
Buy
Common Stock
P-Purchase
Trieu Vuong
Chairman And CEO
CEO / President 70 000
Value: $6K
Nov 22, 2022
Buy
Common Stock
P-Purchase
Trieu Vuong
Chairman And CEO
CEO / President 70 000
Value: $6K
Sep 26, 2022
Buy
Common Stock
P-Purchase
Trieu Vuong
Chairman And CEO
CEO / President 20 000
Value: $1K
Sep 26, 2022
Buy
Common Stock
P-Purchase
Trieu Vuong
Chairman And CEO
CEO / President 20 000
Value: $1K
Aug 25, 2022
Buy
Common Stock
P-Purchase
Trieu Vuong
Chairman And CEO
CEO / President 80 000
Value: $7K
Aug 25, 2022
Buy
Common Stock
P-Purchase
Trieu Vuong
Chairman And CEO
CEO / President 80 000
Value: $7K
Sep 03, 2021
Buy
Stock Options
A-Award
Trieu Vuong
Chief Executive Officer
CEO / President 225 000
Value: $0
Sep 03, 2021
Buy
Stock Options
A-Award
Maida Anthony E Iii
Chief Clin. Ops. Officer
Officer 600 000
Value: $83.6K
Sep 03, 2021
Buy
Stock Options
A-Award
King Steven W
Director
Director 500 000
Value: $69.7K
Sep 03, 2021
Buy
Stock Options
A-Award
Saund Saran
Chief Business Officer
Officer 675 000
Value: $94.0K
Sep 03, 2021
Buy
Stock Options
A-Award
Saund Saran
Chief Business Officer
Officer 675 000
Value: $94.0K
Sep 03, 2021
Buy
Stock Options
A-Award
King Steven W
Director
Director 500 000
Value: $69.7K
Sep 03, 2021
Buy
Stock Options
A-Award
Maida Anthony E Iii
Chief Clin. Ops. Officer
Officer 600 000
Value: $83.6K
Sep 03, 2021
Buy
Stock Options
A-Award
Trieu Vuong
Chief Executive Officer
CEO / President 225 000
Value: $0
Jul 08, 2021
Buy
Stock Options
A-Award
Maida Anthony E Iii
Chief Clinical Officer
Officer 400 000
Value: $65.0K
Jul 08, 2021
Buy
Common Stock
A-Award
Trieu Vuong
Chairman And CEO
CEO / President 259 302
Value: $0
Jul 08, 2021
Buy
Stock Options
A-Award
Trieu Vuong
Chairman And CEO
CEO / President 513 953
Value: $83.6K
Jul 08, 2021
Buy
Stock Options
A-Award
King Steven W
Director
Director 357 412
Value: $58.1K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT ONCOTELIC THERAPEUTICS, INC.
Oncotelic Therapeutics
Oncotelic Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing drugs for the treatment of orphan oncology indications. The company's lead product candidate is OT-101, an antisense against TGF-ß2, which is in phase 3 clinical trials for pancreatic cancer and glioblastoma, as well as develops OT-101 for the treatment of various viruses, including severe acute respiratory syndrome and coronavirus. It also develops O...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE